NeuroOne Medical Tech (NASDAQ:NMTC) reported quarterly earnings results on February 17, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $-0.03, beating the consensus estimate of $-0.04 by $0.01 per share. Revenue came in at $2.9M, beating the estimate of $2.7M.
NeuroOne Medical Tech's stock moved following the earnings release. The stock currently trades at $0.72 with a market capitalization of $29.3M.


